Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Orbit Discovery

Orbit Discovery

Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.

OverviewStructured DataIssuesContributorsActivity

All edits by  James Smith 

Edits on 30 Apr, 2019
James Smith profile picture
James Smith
approved a suggestion from Golden's AI on 30 Apr, 2019
Edits made to:
Article (+17/-17 characters)
Article

On May 23, 2018 Orbit Discovery closed a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation, joined by new investors RT Ventures, Borealis VenturesBorealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants' Partner James Mallinson became Board of Directors at Orbit Discovery.

Find more companies like Orbit Discovery

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.